Clinuvel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CUVL and other ETFs, options, and stocks.About CUVL
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug.
CEOPhilippe Jacques Wolgen, MD, MBA
CEOPhilippe Jacques Wolgen, MD, MBA
Employees—
Employees—
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded1999
Founded1999
Employees—
Employees—
CUVL Key Statistics
Market cap376.38M
Market cap376.38M
Price-Earnings ratio17.78
Price-Earnings ratio17.78
Dividend yield0.38%
Dividend yield0.38%
Average volume6.53K
Average volume6.53K
High today—
High today—
Low today—
Low today—
Open price$7.30
Open price$7.30
Volume0.00
Volume0.00
52 Week high$9.00
52 Week high$9.00
52 Week low$5.98
52 Week low$5.98
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.